Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Nanozyme-Mediated Joint Homeostasis Restoration: Emerging Strategies for Arthritis Therapy.

Created on 19 Jul 2026

Authors

Shun Han, Daqing Wang, Hyon-U Pak, Pema Tsering, Baosheng Yin, Hongjing Li

Published in

International journal of nanomedicine. Volume 21. Pages 612956. Epub Jul 14, 2026.

Abstract

Severe oxidative stress and inflammatory cascades drive the pathological progression of rheumatoid arthritis (RA), osteoarthritis (OA), and gouty arthritis (GA). Conventional pharmacotherapies and natural enzyme interventions are frequently constrained by factors such as systemic toxicity and poor intra-articular bioavailability. In contrast, nanozymes have garnered researcher's attention by virtue of their superior physicochemical stability, cost-effectiveness, and tunable reactive oxygen species (ROS) scavenging capacities. They exhibit unique advantages in the field of arthritis therapy, featuring single-atom catalysts, efficient multi-enzyme catalytic activities, and significantly prolonged synovial retention half-lives. To bridge critical gaps in the existing review literature, this review focuses on nanozyme-mediated therapeutics for the three most common types of arthritis, systematically summarizing the latest advancements in this domain. First, the review elucidates the pathomechanisms of RA, OA, and GA to establish a therapeutic rationale. Subsequently, the article traces the evolution of nanozyme engineering designs for specific disease applications. Finally, critical barriers to clinical translation are analyzed, including long-term biosafety, pharmacokinetics, and industrial standardization. This review elucidates the therapeutic functions of nanozymes across distinct pathological microenvironments, establishing a clinical demand-driven classification framework. By mapping material-inherent catalytic properties directly to specific clinical requisites, this article provides actionable insights to bridge the translational gap between fundamental biomaterials research and clinical practice.

PMID:
42471992
Bibliographic data and abstract were imported from PubMed on 19 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement